NASDAQ:DCTH Delcath Systems - DCTH News Today Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Adding Delcath Systems, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. $4.67 +0.16 (+3.55%) (As of 03/23/2023 12:00 AM ET) Add Compare Share Share Today's Range$4.52▼$4.7350-Day Range$3.51▼$5.4552-Week Range$2.34▼$6.82Volume14,679 shsAverage Volume28,641 shsMarket Capitalization$46.93 millionP/E RatioN/ADividend YieldN/APrice Target$17.33 ProfileAnalyst RatingsChartCompetitorsEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesSEC FilingsShort InterestSocial Media Get Delcath Systems News Delivered to You Automatically Sign up to receive the latest news and ratings for DCTH and its competitors with MarketBeat's FREE daily newsletter. Email Address DCTH Media Mentions By Week DCTH Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. DCTH News Sentiment▼-0.530.35▲Average Medical News Sentiment DCTH News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. DCTH Articles This Week▼50▲DCTH Articles Average Week All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineDelcath Systems (DCTH) to Release Quarterly Earnings on Thursdayamericanbankingnews.com - March 22 at 8:48 AMDelcath Systems (DCTH) to Release Earnings on Thursdayamericanbankingnews.com - March 22 at 8:14 AMDelcath Systems (NASDAQ:DCTH) Receives New Coverage from Analysts at StockNews.comamericanbankingnews.com - March 22 at 3:58 AMStockNews.com Initiates Coverage on Delcath Systems (NASDAQ:DCTH)americanbankingnews.com - March 15 at 2:20 AMDelcath Systems appoints chairmanseekingalpha.com - February 18 at 10:02 AMDelcath Announces Rotation of the Board of Directors Chairmanship; John R. Sylvester Appointed New Chairman as Company Prepares for US Commercial Launchfinance.yahoo.com - February 16 at 9:41 AMDelcath Systems to Participate at the BTIG MedTech, Digital Health, Life Sciences & Diagnostic Tools Conference on February 14 to 16finance.yahoo.com - January 30 at 9:57 AMDelcath Systems, Inc. (NASDAQ:DCTH): Are Analysts Optimistic?finance.yahoo.com - January 30 at 7:19 AMDelcath Systems Announces Updated Results from CHOPIN Phase 1b Trial Published in Cardiovascular and Interventional Radiologyfinance.yahoo.com - January 17 at 8:56 AMDelcath Systems Announces Inducement of Grant Under NASDAQ Listing Rule 5635(C)(4)finance.yahoo.com - December 16 at 5:07 PMDelcath Systems Closes Private Placement of $6.2 Millionfinance.yahoo.com - December 13 at 8:55 AMDelcath Shares Climb on $6.2 Million Private Placementmarketwatch.com - December 8 at 8:20 PMDelcath Systems Announces Private Placement of $6.2 Millionfinance.yahoo.com - December 8 at 9:24 AMDelcath Systems's Return On Capital Employed Overviewmsn.com - December 6 at 4:13 PMResults of a Single Center Study on Delcath's CHEMOSAT® Hepatic Delivery System In the Treatment of Cholangiocarcinoma Published in the Journal Clinical & Experimental Metastasisfinance.yahoo.com - December 5 at 5:08 PMDelcath Systems Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)finance.yahoo.com - November 9 at 5:32 PMDelcath Systems, Inc. (DCTH) Reports Q3 Loss, Tops Revenue Estimatesnasdaq.com - November 8 at 3:17 PMDelcath Systems Inc. Q3 Loss beats estimatesnasdaq.com - November 8 at 8:46 AMDelcath Systems Reports Third Quarter 2022 Results and Provides Business Updatefinance.yahoo.com - November 8 at 8:46 AMDelcath Systems to Host Third Quarter 2022 Resultsfinance.yahoo.com - October 24 at 9:12 PMDelcath Systems to Participate at the H.C. Wainwright 24th Annual Global Investor Conference on September 12 and 13, 2022finance.yahoo.com - September 1 at 5:24 PMDelcath Systems (DCTH) Investor Presentation - Slideshowseekingalpha.com - August 19 at 10:52 PMDelcath Systems, Inc. (DCTH) Reports Q2 Loss, Lags Revenue Estimatesnasdaq.com - August 8 at 5:36 PMDelcath Systems, Inc. (DCTH) CEO Gerard Michel on Q2 2022 Results - Earnings Call Transcriptseekingalpha.com - August 8 at 5:36 PMDelcath Systems Reports Second Quarter 2022 Results and Provides Business Updatefinance.yahoo.com - August 8 at 5:36 PMEarnings Outlook For Delcath Systemsmsn.com - August 5 at 2:55 PMResults of a Multicenter Study on Delcath's CHEMOSAT® Hepatic Delivery System Published in Cardiovascular and Interventional Radiologyfinance.yahoo.com - August 5 at 9:54 AMDelcath Systems to Present at Upcoming Investor Conferences in Augustfinance.yahoo.com - July 27 at 8:35 PMThursday 7/21 Insider Buying Report: KDP, DCTHnasdaq.com - July 21 at 3:26 PMDelcath Systems Closes Private Placement of $5.0 Millionfinance.yahoo.com - July 20 at 4:51 PMDelcath Systems Announces Private Placement of $5.0 Millionfinance.yahoo.com - July 18 at 8:47 AMDelcath Systems Stock Jumps After Data Update From Eye Cancer Trials At ASCO Meetingfinance.yahoo.com - June 7 at 10:30 AMThe Daily Biotech Pulse: Veru Seeks Emergency Use Nod For COVID-19 Therapy, Vincerx Cuts Workforce, Moderna Starts Dosing In Flu Vaccine Studymarkets.businessinsider.com - June 7 at 9:57 AMPositive Initial Results from CHOPIN Phase 1b Trial, FOCUS Trial Update and QoL Study Presented at the 2022 ASCO Annual Meetingfinance.yahoo.com - June 6 at 6:29 PMDelcath Systems Ltd. (DCTH) CEO Gerard Michel on Q1 2022 Results - Earnings Call Transcriptseekingalpha.com - May 10 at 3:27 PMDelcath Systems, Inc. (DCTH) Reports Q1 Loss, Misses Revenue Estimatesnasdaq.com - May 10 at 12:44 PMDelcath Systems Inc. Q1 Loss misses estimatesnasdaq.com - May 10 at 8:50 AMDelcath Systems Reports First Quarter 2022 Results and Provides Business Updatefinance.yahoo.com - May 10 at 8:50 AMDelcath Systems Q1 2022 Earnings Previewseekingalpha.com - May 9 at 1:22 PMDelcath Announces Poster Presentation at the 2022 ASCO Annual Meetingfinance.yahoo.com - May 9 at 9:13 AMDelcath Systems to Host First Quarter 2022 Resultsfinance.yahoo.com - April 28 at 9:13 AMWednesday 4/13 Insider Buying Report: DCTH, CSPInasdaq.com - April 13 at 3:21 PMDelcath Systems to Participate in the Canaccord Genuity Horizons in Oncology Conferencefinance.yahoo.com - April 8 at 11:53 AMDelcath Systems to Participate in the Lytham Partners Spring 2022 Investor Conferencefinance.yahoo.com - March 29 at 11:34 AMDelcath Systems, Inc. (DCTH) Reports Q4 Loss, Tops Revenue Estimatessg.finance.yahoo.com - March 25 at 5:01 PMDelcath Systems Reports Fourth Quarter and Full-Year 2021 Results and Provides Business Updatefinance.yahoo.com - March 25 at 8:11 AMDelcath Systems's Earnings Outlookbenzinga.com - March 24 at 5:05 PMDelcath Systems is about to announce its earnings — here's what Wall Street expectsmarkets.businessinsider.com - March 24 at 11:26 AMDelcath Systems Earnings Conference Call Is Coming Up, Here's What You Need To Knowbenzinga.com - March 24 at 9:54 AMDelcath Systems to Present at the 34th Annual Roth Conferencefinance.yahoo.com - March 10 at 9:40 AM Get Delcath Systems News Delivered to You Automatically Sign up to receive the latest news and ratings for DCTH and its competitors with MarketBeat's FREE daily newsletter. Email Address This page (NASDAQ:DCTH) was last updated on 3/23/2023 by MarketBeat.com Staff Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.